InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: davidal66 post# 291

Wednesday, 05/18/2016 8:42:10 PM

Wednesday, May 18, 2016 8:42:10 PM

Post# of 2099
Celldex bellyflop has been discussed in the last two sessions. Check out:

1) Key Opinion Leader Meeting; and
http://lifesci.rampard.com/20160504/reg.jsp

2) Earnings q & a
http://seekingalpha.com/article/3974924-vascular-biogenics-vblt-ceo-dror-harats-q1-2016-results-earnings-call-transcript?part=single

It has to do with patient selection. Celldex selected patients to get favorable results in phase 2 and bombed in phase 3. VBLT phase 2 patient is the same as phase 3. No guarantee for success but higher chance at replicating success in phase 2.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News